Cargando…
Ectromelia Virus Disease Characterization in the BALB/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures
In 2007, the United States– Food and Drug Administration (FDA) issued guidance concerning animal models for testing the efficacy of medical countermeasures against variola virus (VARV), the etiologic agent for smallpox. Ectromelia virus (ECTV) is naturally-occurring and responsible for severe mortal...
Autores principales: | Garver, Jennifer, Weber, Lauren, Vela, Eric M., Anderson, Mike, Warren, Richard, Merchlinsky, Michael, Houchens, Christopher, Rogers, James V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974538/ https://www.ncbi.nlm.nih.gov/pubmed/27455306 http://dx.doi.org/10.3390/v8070203 |
Ejemplares similares
-
Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule
por: Perry, Mark R., et al.
Publicado: (2018) -
Developing new smallpox vaccines.
por: Rosenthal, S R, et al.
Publicado: (2001) -
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014) -
A rapid detection method for Vaccinia virus, the surrogate for smallpox virus
por: Donaldson, Kim A, et al.
Publicado: (2004) -
Smallpox vaccination in a mouse model
por: Shchelkunov, S.N., et al.
Publicado: (2023)